Akebia Therapeutics, Inc. (AKBA)

1.555 -0.06 (-3.42%) USD  |  NASDAQ  |  Jan 02, 16:00
1.59 +0.04 (+2.25%) After-Hours: 19:19
More

Akebia Therapeutics Change in Receivables (Quarterly)

Change in Receivables (Quarterly) Chart

View Change in Receivables (Quarterly) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (Quarterly) Range, Past 5 Years

View Change in Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (Quarterly) Benchmarks

View Change in Receivables (Quarterly) Benchmarks
Start Trial
Pfizer Inc. --
Plus Therapeutics, Inc. --
Ironwood Pharmaceuticals, Inc. Upgrade
Pyxis Oncology, Inc. --
Theravance Biopharma, Inc. Upgrade